APA (7th ed.) Citation

Elizabeth D. Slaney, Renee Modica, Renee Modica, Leandra Woolnough, Leandra Woolnough, Dina Kafisheh, . . . Melissa Elder. (2024). Case Report: Refractory macrophage activation syndrome requiring high-dose anakinra, emapalumab, and etoposide therapy in early-onset systemic juvenile idiopathic arthritis associated with adenoviremia. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Elizabeth D. Slaney, et al. Case Report: Refractory Macrophage Activation Syndrome Requiring High-dose Anakinra, Emapalumab, and Etoposide Therapy in Early-onset Systemic Juvenile Idiopathic Arthritis Associated with Adenoviremia. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Elizabeth D. Slaney, et al. Case Report: Refractory Macrophage Activation Syndrome Requiring High-dose Anakinra, Emapalumab, and Etoposide Therapy in Early-onset Systemic Juvenile Idiopathic Arthritis Associated with Adenoviremia. Frontiers Media S.A., 2024.